Notice Information
Notice Title
Element AVITI24 Upgrade
Notice Description
The Genetics Core is embedded within the Edinburgh Clinical Research Facility, which has been accredited under the Medicines and Healthcare Products Regulatory Agency (MHRA) Phase I Accreditation Scheme since July 2011. The Genetics Core purchased the original equipment in 2024, which is a relatively new-to-market short-read sequencing platform. The request in this Non-Competitive Action is to upgrade the existing equipment, which entails a hardware change to the camera and compute.
Lot Information
Lot 1
The Genetics Core is embedded within the Edinburgh Clinical Research Facility, which has been accredited under the Medicines and Healthcare Products Regulatory Agency (MHRA) Phase I Accreditation Scheme since July 2011. The Genetics Core purchased the original equipment in 2024, which is a relatively new-to-market short-read sequencing platform. The request in this Non-Competitive Action is to upgrade the existing equipment, which entails a hardware change to the camera and compute.
Procurement Information
The Genetics Core is embedded within the Edinburgh Clinical Research Facility, which has been accredited under the Medicines and Healthcare Products Regulatory Agency (MHRA) Phase I Accreditation Scheme since July 2011. The Genetics Core purchased the original equipment in 2024, which is a relatively new-to-market short-read sequencing platform. The request in this Non-Competitive Action is to upgrade the existing equipment, which entails a hardware change to the camera and compute. This request builds on the initial investment and allows two new functionalities; a) Increased throughput & cost saving: The upgrade enables ~50% increase in sequencing output for no extra reagent or processing cost e.g. High output flow cell increases from 1B reads to 1.5B reads. This results in a cost saving each time the platform is run. The trend of direction in genomics is for higher throughput sequencing, especially in the fields of single-cell (10x, Parse) and spatial biology (Visium, Nanostring GeoMx). b) Simultaneous multi-omic profiling at the single cell level: The upgrade allows the exciting ability to allow in-sample omics profiling so that transcriptomics and proteomics occur within the cell, without the need for DNA or RNA extraction. This in-situ sequencing on the platform allows co-detection of RNA, protein, and cell morphology at subcellular spatial resolution. For example, the curated neuroscience panel available from Element contains RNA, protein & cell painting markers to study neurodegenerative disorders, like Alzheimer's and Parkinson's disease, psychiatric disorders, and neurological cancers. It can unravel the complexities of neuroscience, from understanding inflammation and identifying key drivers of neural cell function to exploring neuronal differentiation and shedding light on disease progression mechanisms. The main new research activity will enable the ability for in-situ multi-omics analysis. This novel technique allows sequencing within living cells without the need for lysis. In addition, the 50% increase in sequencing throughput will allow the Genetics Core to ensure demand is met, the centralisation of genomics and the expected increase in projects and researchers using the Genetics Core. The proposed procurement route is a Non-Competitive Action (NCA), as Element are the only provider that can upgrade their equipment. Further details in this document justify this approach as a compliant route to market.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000817736
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC545004
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- PCS Notice - Website Contract Award Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
42 - Industrial machinery
-
- CPV Codes
42931100 - Laboratory centrifuges and accessories
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £99,225 Under £100K
Notice Dates
- Publication Date
- 5 Dec 20252 months ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 4 Dec 20252 months ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Not Specified
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- UNIVERSITY OF EDINBURGH
- Contact Name
- Suzanne Toole
- Contact Email
- suzie.toole@ed.ac.uk
- Contact Phone
- Not specified
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH1 1HT
- Post Town
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM75 City of Edinburgh
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- City Centre
- Westminster Constituency
- Edinburgh East and Musselburgh
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC545004
Element AVITI24 Upgrade - The Genetics Core is embedded within the Edinburgh Clinical Research Facility, which has been accredited under the Medicines and Healthcare Products Regulatory Agency (MHRA) Phase I Accreditation Scheme since July 2011. The Genetics Core purchased the original equipment in 2024, which is a relatively new-to-market short-read sequencing platform. The request in this Non-Competitive Action is to upgrade the existing equipment, which entails a hardware change to the camera and compute.
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-r6ebe6-0000817736-2025-12-05T00:00:00Z",
"date": "2025-12-05T00:00:00Z",
"ocid": "ocds-r6ebe6-0000817736",
"initiationType": "tender",
"parties": [
{
"id": "org-27",
"name": "University Of Edinburgh",
"identifier": {
"legalName": "University Of Edinburgh"
},
"address": {
"streetAddress": "Charles Stewart House, 9-16 Chambers Street",
"locality": "Edinburgh",
"region": "UKM75",
"postalCode": "EH1 1HT"
},
"contactPoint": {
"name": "Suzanne Toole",
"email": "suzie.toole@ed.ac.uk",
"url": "http://"
},
"roles": [
"buyer"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "09",
"description": "Education",
"scheme": "COFOG"
}
],
"url": "http://www.ed.ac.uk"
}
},
{
"id": "org-106",
"name": "Element Biosciences",
"identifier": {
"legalName": "Element Biosciences"
},
"address": {
"streetAddress": "Keizersgracht 391 A",
"locality": "Amsterdam",
"region": "UKZZZ",
"postalCode": "1016EJ"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-21",
"name": "Edinburgh Sheriff Court",
"identifier": {
"legalName": "Edinburgh Sheriff Court"
},
"address": {
"locality": "Edinburgh",
"postalCode": "EH1 1LB"
},
"contactPoint": {
"url": "http://"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"name": "University Of Edinburgh",
"id": "org-27"
},
"tender": {
"id": "NCA21367",
"title": "Element AVITI24 Upgrade",
"description": "The Genetics Core is embedded within the Edinburgh Clinical Research Facility, which has been accredited under the Medicines and Healthcare Products Regulatory Agency (MHRA) Phase I Accreditation Scheme since July 2011. The Genetics Core purchased the original equipment in 2024, which is a relatively new-to-market short-read sequencing platform. The request in this Non-Competitive Action is to upgrade the existing equipment, which entails a hardware change to the camera and compute.",
"status": "complete",
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UKM75"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationale": "The Genetics Core is embedded within the Edinburgh Clinical Research Facility, which has been accredited under the Medicines and Healthcare Products Regulatory Agency (MHRA) Phase I Accreditation Scheme since July 2011. The Genetics Core purchased the original equipment in 2024, which is a relatively new-to-market short-read sequencing platform. The request in this Non-Competitive Action is to upgrade the existing equipment, which entails a hardware change to the camera and compute. This request builds on the initial investment and allows two new functionalities; a) Increased throughput & cost saving: The upgrade enables ~50% increase in sequencing output for no extra reagent or processing cost e.g. High output flow cell increases from 1B reads to 1.5B reads. This results in a cost saving each time the platform is run. The trend of direction in genomics is for higher throughput sequencing, especially in the fields of single-cell (10x, Parse) and spatial biology (Visium, Nanostring GeoMx). b) Simultaneous multi-omic profiling at the single cell level: The upgrade allows the exciting ability to allow in-sample omics profiling so that transcriptomics and proteomics occur within the cell, without the need for DNA or RNA extraction. This in-situ sequencing on the platform allows co-detection of RNA, protein, and cell morphology at subcellular spatial resolution. For example, the curated neuroscience panel available from Element contains RNA, protein & cell painting markers to study neurodegenerative disorders, like Alzheimer's and Parkinson's disease, psychiatric disorders, and neurological cancers. It can unravel the complexities of neuroscience, from understanding inflammation and identifying key drivers of neural cell function to exploring neuronal differentiation and shedding light on disease progression mechanisms. The main new research activity will enable the ability for in-situ multi-omics analysis. This novel technique allows sequencing within living cells without the need for lysis. In addition, the 50% increase in sequencing throughput will allow the Genetics Core to ensure demand is met, the centralisation of genomics and the expected increase in projects and researchers using the Genetics Core. The proposed procurement route is a Non-Competitive Action (NCA), as Element are the only provider that can upgrade their equipment. Further details in this document justify this approach as a compliant route to market.",
"mainProcurementCategory": "goods",
"documents": [
{
"id": "DEC545004",
"documentType": "awardNotice",
"title": "Element AVITI24 Upgrade",
"description": "The Genetics Core is embedded within the Edinburgh Clinical Research Facility, which has been accredited under the Medicines and Healthcare Products Regulatory Agency (MHRA) Phase I Accreditation Scheme since July 2011. The Genetics Core purchased the original equipment in 2024, which is a relatively new-to-market short-read sequencing platform. The request in this Non-Competitive Action is to upgrade the existing equipment, which entails a hardware change to the camera and compute.",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC545004",
"format": "text/html"
}
],
"lots": [
{
"id": "1",
"description": "The Genetics Core is embedded within the Edinburgh Clinical Research Facility, which has been accredited under the Medicines and Healthcare Products Regulatory Agency (MHRA) Phase I Accreditation Scheme since July 2011. The Genetics Core purchased the original equipment in 2024, which is a relatively new-to-market short-read sequencing platform. The request in this Non-Competitive Action is to upgrade the existing equipment, which entails a hardware change to the camera and compute.",
"status": "complete",
"hasOptions": false
}
],
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"id": "D_TECHNICAL",
"description": "The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
}
],
"classification": {
"id": "42931100",
"scheme": "CPV"
}
},
"awards": [
{
"id": "NCA21367",
"suppliers": [
{
"id": "org-106",
"name": "Element Biosciences"
}
],
"relatedLots": [
"1"
]
}
],
"contracts": [
{
"id": "NCA21367",
"awardID": "NCA21367",
"status": "active",
"value": {
"amount": 99225,
"currency": "GBP"
},
"dateSigned": "2025-12-04T00:00:00Z"
}
],
"language": "EN",
"description": "(SC Ref:817736)",
"bids": {
"statistics": [
{
"id": "261",
"measure": "bids",
"value": 1,
"relatedLot": "1"
},
{
"id": "262",
"measure": "smeBids",
"value": 0,
"relatedLot": "1"
},
{
"id": "263",
"measure": "foreignBidsFromEU",
"value": 1,
"relatedLot": "1"
},
{
"id": "264",
"measure": "foreignBidsFromNonEU",
"value": 0,
"relatedLot": "1"
},
{
"id": "265",
"measure": "electronicBids",
"value": 1,
"relatedLot": "1"
}
]
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000817736"
}
],
"noticetype": "PCS Notice - Website Contract Award Notice"
}